Reinventing Lipid Nanoparticles

CEO John Lewis chatted with Kevin Folta of the Talking Biotech Podcast, a weekly podcast that uncovers the stories, ideas, and research of people at the frontier of biology and engineering.  

Listen to their insightful conversation about the advantages  using lipid nanoparticles (LNPs) for drug delivery along with the promise of Entos’ Fusogenix Proteolipid Vehicle (PLV) technology. The podcast is available on Apple Podcasts, Google Podcasts, and Spotify, and you can also listen at the link below. Enjoy!

Talking Biotech Podcast 385
Entos Pharmaceuticals

33 St James's Square
London, UK, SW1Y 4JS

Unit 4550, 10230 Jasper Avenue
Edmonton, Alberta, Canada
T5J 4P6

3040 Science Park Road,Suite 1100
San Diego, CA 92121

General Contact
Tel: 1-800-727-0884

Investor Contact

Media Contact
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.